Home < 科学研究 < 文章摘要 < 

文章摘要

Clinical Trial

2020 Nov 11.

JOURNAL:Circulation.

Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial

SD Anker, J Butler, EMPEROR-Reduced Trial Committees and Investigators et al.

18111

Keywords: cardiorenal outcomes; empagliflozin

Full Text PDF